Loading...

Linike Medical Group Ltd

LNMGPNK
Financial Services
Shell Companies
$0.01
$-0.01(-52.94%)
U.S. Market opens in 17h 3m

Linike Medical Group Ltd (LNMG) Stock Overview

Explore Linike Medical Group Ltd’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.1M
P/E Ratio12.69
EPS (TTM)$0.01
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$0.00

LNMG Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Linike Medical Group Ltd (LNMG) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 8.26, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 12.69 and a market capitalization of 6.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-52.94%
5-Day Change
-52.94%
1-Month Change
-52.94%
3-Month Change
-32.28%
6-Month Change
-52.00%
Year-to-Date (YTD) Change
-69.23%
1-Year Change
96.72%
3-Year Change
-99.75%
5-Year Change
8.11%
All-Time (Max) Change
-99.52%

Contact Information

NaN
833–1st Avenue NW, Calgary, AB, T2N 0A4

Company Facts

IPO DateJun 12, 2012
CountryCA
Actively Trading

Frequently Asked Questions